Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?
Fabián Sanchis‐Gomar, Carl J. Lavie, Daniel P. Morin, Carme Pérez-Quilis, Jari A. Laukkanen, Marco Pérez
Topics & Concepts
AmiodaroneMedicineCoronavirus disease 2019 (COVID-19)DrugPharmacotherapySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Intensive care medicineCoronavirus2019-20 coronavirus outbreakInternal medicineCardiologyPharmacologyDiseaseAtrial fibrillationVirologyInfectious disease (medical specialty)OutbreakCardiac electrophysiology and arrhythmiasSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies